Table 2.
Univariate and multivariate analysis for OS of CRC patients
| Variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
|
| ||||
| RR (95% CI) | P value | RR (95% CI) | P value | |
| Age (year) | 0.625 (0.462-2.512) | 1.57 | ||
| Sex | 0.452 (0.721-1.835) | 0.76 | ||
| Tumour site | 0.937 (0.682-2.317) | 2.65 | ||
| Tumour histology | 0.720 (0.839-3.371) | 3.06 | ||
| Clinical stage | 2.326 (1.417-3.282) | 0.038* | 1.05 (1.581-2.372) | 0.018* |
| Lymph node metastasis | 0.472 (0.621-2.371) | 1.75 | ||
| long non-coding RNA FTX expression | 1.261 (1.593-2.478) | 0.0007* | 2.371 (1.42-2.739) | 0.00041* |
| Lymph vascular invasion | 0.571 (0.489-1.804) | 0.47 | ||
| Differentiation grade | 1.427 (1.904-2.074) | 0.018* | 1.273 (2.83-4.278) | 0.029* |
| Perineural invasion | 1.581 (1.342-2.581) | 0.053 | ||
*
P < 0.05.
HR: hazard ratio; 95% CI: 95% confidence interval.